Oscar Health, Inc. (OSCR) shares surged 15.13% in pre-market trading on Friday, as investors reacted to the company's exceptional Q1 2025 results and the potential impact of proposed Medicare Part E legislation. The tech-native insurer has successfully transformed from a money-losing startup to a profitable growth story, validating its digital-first model in the health insurance industry.
The company reported a net income of $275 million on $3 billion in revenue for Q1 2025, representing a 42% year-over-year growth. This performance significantly exceeded analyst expectations, with diluted earnings per share of $0.92 surpassing consensus estimates by over 14%. Oscar Health's operational improvements were evident in its record-low SG&A ratio of 15.8% and an improved medical loss ratio of 75.4%.
Adding to the optimism surrounding Oscar Health is the recently introduced Choose Medicare Act, which proposes a Medicare Part E public option available through ACA marketplaces. If passed, this legislation could substantially expand Oscar's addressable market, potentially tripling it. The company's established infrastructure and experience in operating profitably in individual markets through digital distribution on government exchanges position it favorably to capitalize on this potential opportunity.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。